Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | CDC72 | 0.0194 | 0.2014 | 0.5 |
Trypanosoma cruzi | choline/carnitine O-acyltransferase, putative | 0.0141 | 0.1426 | 0.6841 |
Leishmania major | choline/Carnitine o-acyltransferase-like protein | 0.0141 | 0.1426 | 0.6841 |
Trypanosoma brucei | N-myristoyltransferase | 0.0194 | 0.2014 | 1 |
Brugia malayi | N-myristoyltransferase 2 | 0.0194 | 0.2014 | 1 |
Brugia malayi | Choline/Carnitine o-acyltransferase family protein | 0.0026 | 0.0152 | 0.0755 |
Plasmodium falciparum | glycylpeptide N-tetradecanoyltransferase | 0.0194 | 0.2014 | 0.5 |
Brugia malayi | TAZ zinc finger family protein | 0.0099 | 0.0962 | 0.4774 |
Leishmania major | N-myristoyl transferase, putative | 0.0194 | 0.2014 | 1 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.0194 | 0.2014 | 1 |
Entamoeba histolytica | glycylpeptide N-tetradecanoyltransferase, putative | 0.0194 | 0.2014 | 0.5 |
Brugia malayi | Choline O-acetyltransferase | 0.0026 | 0.0152 | 0.0755 |
Trypanosoma cruzi | choline/carnitine O-acyltransferase, putative | 0.0141 | 0.1426 | 0.6841 |
Echinococcus multilocularis | carnitine O palmitoyltransferase 2 | 0.0026 | 0.0152 | 0.0755 |
Echinococcus multilocularis | CREB binding protein | 0.0016 | 0.0045 | 0.0226 |
Schistosoma mansoni | CREB-binding protein 2 | 0.0099 | 0.0962 | 0.4774 |
Schistosoma mansoni | N-myristoyltransferase | 0.0194 | 0.2014 | 1 |
Loa Loa (eye worm) | carnitine O-palmitoyltransferase I isoform | 0.0026 | 0.0152 | 0.0755 |
Echinococcus granulosus | carnitine O palmitoyltransferase 2 | 0.0026 | 0.0152 | 0.0755 |
Trichomonas vaginalis | N-myristoyl transferase, putative | 0.0128 | 0.1277 | 0.6342 |
Brugia malayi | Choline/Carnitine o-acyltransferase family protein | 0.0026 | 0.0152 | 0.0755 |
Echinococcus multilocularis | CREB binding protein | 0.0068 | 0.0617 | 0.3064 |
Echinococcus multilocularis | glycylpeptide N tetradecanoyltransferase | 0.0194 | 0.2014 | 1 |
Brugia malayi | Choline/Carnitine o-acyltransferase family protein | 0.0141 | 0.1426 | 0.7079 |
Onchocerca volvulus | 0.0026 | 0.0152 | 0.5 | |
Loa Loa (eye worm) | choline O-acetyltransferase | 0.0026 | 0.0152 | 0.0755 |
Echinococcus granulosus | CREB binding protein | 0.0016 | 0.0045 | 0.0226 |
Echinococcus multilocularis | carnitine O palmitoyltransferase 1, liver | 0.0141 | 0.1426 | 0.7079 |
Echinococcus granulosus | carnitine O palmitoyltransferase 1 liver | 0.0141 | 0.1426 | 0.7079 |
Loa Loa (eye worm) | choline/Carnitine O-acyltransferase | 0.0026 | 0.0152 | 0.0755 |
Mycobacterium tuberculosis | Naphthoate synthase MenB (dihydroxynaphthoic acid synthetase) (DHNA synthetase) | 0.0917 | 1 | 0.5 |
Echinococcus granulosus | CREB binding protein | 0.0099 | 0.0962 | 0.4774 |
Loa Loa (eye worm) | N-myristoyltransferase 2 | 0.0194 | 0.2014 | 1 |
Onchocerca volvulus | 0.0026 | 0.0152 | 0.5 | |
Trichomonas vaginalis | N-myristoyl transferase, putative | 0.0194 | 0.2014 | 1 |
Mycobacterium ulcerans | naphthoate synthase | 0.0917 | 1 | 0.5 |
Schistosoma mansoni | CREB-binding protein 1 (SmCBP1) | 0.0099 | 0.0962 | 0.4774 |
Brugia malayi | Choline O-acetyltransferase | 0.0026 | 0.0152 | 0.0755 |
Echinococcus granulosus | CREB binding protein | 0.0061 | 0.0542 | 0.2689 |
Schistosoma mansoni | choline o-acyltransferase | 0.0026 | 0.0152 | 0.0755 |
Onchocerca volvulus | 0.0026 | 0.0152 | 0.5 | |
Echinococcus granulosus | CREB binding protein | 0.0016 | 0.0045 | 0.0226 |
Trypanosoma brucei | N-myristoyl transferase, putative | 0.0194 | 0.2014 | 1 |
Onchocerca volvulus | 0.0026 | 0.0152 | 0.5 | |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.038 | 0.1888 |
Echinococcus granulosus | choline O acetyltransferase | 0.0026 | 0.0152 | 0.0755 |
Echinococcus multilocularis | CREB binding protein | 0.0016 | 0.0045 | 0.0226 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0141 | 0.1426 | 0.7079 |
Loa Loa (eye worm) | CBP-B | 0.0069 | 0.0627 | 0.3112 |
Schistosoma mansoni | choline o-acyltransferase | 0.0026 | 0.0152 | 0.0755 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.0194 | 0.2014 | 1 |
Plasmodium vivax | glycylpeptide N-tetradecanoyltransferase, putative | 0.0194 | 0.2014 | 1 |
Echinococcus granulosus | glycylpeptide N tetradecanoyltransferase | 0.0194 | 0.2014 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0152 | 0.0755 |
Echinococcus multilocularis | CREB binding protein | 0.0016 | 0.0045 | 0.0226 |
Echinococcus multilocularis | choline O acetyltransferase | 0.0026 | 0.0152 | 0.0755 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 3.0969 | Antitumor activity against human A549 cells after 4 hrs by MTT assay | ChEMBL. | 18207748 |
IC50 (functional) | = 0.0008 uM | Antitumor activity against human A549 cells after 4 hrs by MTT assay | ChEMBL. | 18207748 |
IC50 (functional) | = 0.0008 uM | Antitumor activity against human A549 cells after 4 hrs by MTT assay | ChEMBL. | 18207748 |
IC50 (functional) | = 0.014 uM | Antitumor activity against human LOVO cells after 4 hrs by MTT assay | ChEMBL. | 18207748 |
IC50 (functional) | = 0.014 uM | Antitumor activity against human LOVO cells after 4 hrs by MTT assay | ChEMBL. | 18207748 |
IC50 (functional) | = 9.245 uM | Antitumor activity against human MCF7 cells after 4 hrs by MTT assay | ChEMBL. | 18207748 |
IC50 (functional) | = 9.245 uM | Antitumor activity against human MCF7 cells after 4 hrs by MTT assay | ChEMBL. | 18207748 |
Log IC50 (functional) | = 3.0969 | Antitumor activity against human A549 cells after 4 hrs by MTT assay | ChEMBL. | 18207748 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 18207748 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.